Current Research Towards Optimizing Dosing of First-Line Antituberculosis Treatment

Expert Review of Anti-Infective Therapy - United Kingdom
doi 10.1080/14787210.2019.1555031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Diagnostic Accuracy and Reproducibility of WHO-Endorsed Phenotypic Drug Susceptibility Testing Methods for First-Line and Second-Line Antituberculosis Drugs

Journal of Clinical Microbiology
Microbiology
2012English

Atezolizumab for the First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC): Current Status and Future Prospects

Frontiers in Oncology
Cancer ResearchOncology
2018English

Cetuximab in First Line Treatment of Metastatic Colorectal Cancer

Farmeconomia. Health economics and therapeutic pathways
2012English

Former First-Line Antibiotics for Treatment of Enteric Fever

The Lancet Infectious Diseases
Infectious Diseases
2016English

Optimal First‐line Treatment for Advanced Thymic Carcinoma

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Establishment of a First‑line Second‑line Treatment Model for Human Pulmonary Adenocarcinoma

Oncology Letters
Cancer ResearchOncology
2016English

First-Line Treatment of Metastatic Lung Cancer—New Developments

Oncology & Hematology Review (US)
2008English

Towards an Australian Event Research Agenda: First Steps

Event Management
Hospitality ManagementBusinessMarketingInternational ManagementLeisureTourism
2000English

First-Line Treatment of Chronic Lymphocytic Leukemia: Role of Alemtuzumab

OncoTargets and Therapy
OncologyPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy